-
Tytuł:
-
Comparison of outcomes between Aurolab aqueous drainage implant placed in the superotemporal versus inferonasal quadrant.
-
Autorzy:
-
Puthuran GV; Glaucoma, Aravind Eye Hospital, Madurai, Tamil Nadu, India .
Palmberg PF; Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, USA.
Wijesinghe HK; Glaucoma, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
Shreya TS; Glaucoma, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
Krishnadas SR; Glaucoma, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
Gedde SJ; Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA.
Robin AL; Glaucoma, Johns Hopkins University, Baltimore, Maryland, USA.
-
Źródło:
-
The British journal of ophthalmology [Br J Ophthalmol] 2021 Apr; Vol. 105 (4), pp. 521-525. Date of Electronic Publication: 2020 Jun 17.
-
Typ publikacji:
-
Comparative Study; Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Publication: Jan. 1992- : London : BMJ Pub. Group
Original Publication: 1917-Dec. 1991: London : British Medical Association
-
MeSH Terms:
-
Glaucoma Drainage Implants*
Visual Acuity*
Glaucoma/*surgery
Intraocular Pressure/*physiology
Prosthesis Implantation/*methods
Adult ; Female ; Follow-Up Studies ; Glaucoma/physiopathology ; Humans ; Male ; Middle Aged ; Reoperation ; Retrospective Studies ; Treatment Outcome
-
Contributed Indexing:
-
Keywords: glaucoma; intraocular pressure; treatment surgery
-
Entry Date(s):
-
Date Created: 20200620 Date Completed: 20210614 Latest Revision: 20210614
-
Update Code:
-
20240105
-
DOI:
-
10.1136/bjophthalmol-2019-315558
-
PMID:
-
32554442
-
Aim: To determine the outcomes of Aurolab aqueous drainage implant (AADI) placed in the superotemporal versus the inferonasal quadrant in adult eyes with refractory glaucoma.
Methods: This was a retrospective study of eyes that had AADI placement and completed a minimum of 2-year follow-up. The choice of the quadrant was at the surgeon's discretion and mainly depended on the amount of scarring and conjunctival mobility. The cumulative failure rate of the AADI was defined as intraocular pressure (IOP) >21 mm Hg or not reduced by 20% below baseline on two consecutive follow-up visits after 3 months, IOP ≤5 mm Hg on two consecutive follow-up visits after 3 months, reoperation for glaucoma or a complication, or loss of light perception vision.
Results: We included 84 eyes with AADI in the inferonasal quadrant versus 69 eyes in the superotemporal quadrant. A significant drop in IOP was seen in both groups (18.4±10.4 mm Hg in the inferonasal group vs 17.7±11.1 mm Hg in the superotemporal group; p=0.63) at 3-month follow-up and this was maintained until last follow-up. Best-corrected visual acuity, IOP, number of IOP-lowering medications and complications were similar between the two groups at all time points. The cumulative success rate at 2-year follow-up without IOP-lowering medications was 57.1% (47.1%-68.1%) in the inferonasal group and 50.7% (39.8%-63.1%) in the superotemporal group (p=0.47).
Conclusions: Inferonasal AADI placement appears to be an equally safe and effective surgical option compared with superotemporal AADI placement and may be helpful in certain clinical situations.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
